Tailoring foods to match people's genes in New Zealand: Opportunities for collaboration

World Review of Nutrition and Dietetics

Volumn 101, Issue , 2010, Pages 169-175

  Ferguson, Lynnette R ^a,b   Hu, Rong ^a,b   Lam, Wen Jiun ^a,b   Munday, Karen ^a,b   Triggs, Christopher M ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Nutrigenomics New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; DIET THERAPY; DISEASE MODEL; ENTERITIS; GENETICS; GENOTYPE; HUMAN; NEW ZEALAND; NUTRIGENOMICS; PUBLIC RELATIONS; REVIEW; STANDARD;

ANIMALS; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERINSTITUTIONAL RELATIONS; NEW ZEALAND; NUTRIGENOMICS; NUTRITION THERAPY;

EID: 84926075751     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000314521     Document Type: Conference Paper

References (26)

1. www.nutrigenomics.org.nz
2. Gearry RB, Richardson A, Frampton CM, et al: High incidence of Crohn's disease in Canterbury New Zealand: results of an epidemiologic study. Inflamm Bowel Dis 2006;12:936-943.
3. Spehlmann ME, Begun AZ, Burghardt J, et al: Epidemiology of inflammatory bowel disease in a German twin cohort results of a nationwide study. Inflamm Bowel Dis 2008;7:968-976.
4. Hunter JO: Nutritional factors in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1998;3: 235-237.
5. Hugot JP, Chamaillard M, Zouali H, et al: Thomas Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
6. Barrett JC, Hansoul S, Nicolae DL, et al: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008; 40:955-962.
7. Browning BL, Huebner C, Petermann I, et al: Association of DLG5 variants with inflammatory bowel disease in the New Zealand Caucasian population and meta-analysis of the DLG5 R30Q variant. Inflamm Bowel Dis 2007;13;9:1069-1076.
8. Huebner C, Ferguson LR, Han DY, et al: Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand Caucasian population: a case-control study. BMC Res Notes 2009;2:52.
9. Gearry RB, Roberts RL, Burt MJ, et al: Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 2007; 13:1220-1227.
10. Browning BL, Huebner C, Petermann I, et al: Has tolllike receptor 4 been prematurely rejected as an inflammatory bowel disease gene? Association study combined with meta-analysis shows strong evidence for association. Am J Gastroenterol 2007;102:2504-2512.
11. Ferguson LR, Huebner C, Petermann I, et al: Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk. World J Gastroenterol 2008;14;29:4652-4661.
12. Ferguson LR, Han DY, Huebner C, et al: Tumor necrosis factor receptor superfamily member 1b haplotypes increase or decrease the risk of inflammatory bowel diseases in a New Zealand Caucasian population. Gastroenterol Res Pract 2009, E-pub ahead of print.
13. Baker PI, Love DR, Ferguson LR: Role of gut micro-biota in Crohn's disease. Expert Rev Gastroenterol Hepatol 2009;3:535-546.
14. Petermann I, Triggs CM, Huebner C, McCulloch A, Ferguson LR: Mushroom intolerance: a novel diet-gene interaction in Crohn's disease. Br J Nutr 2009; 102:506-508.
15. Petermann I, Huebner C, Browning BL, et al: Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort. Hum Immunol. 2009;70:440-446.
16. Philpott M, Mackay L, Ferguson LR, Forbes D, Skinner M: Cell culture models in developing nutrigenomics foods for inflammatory bowel disease. Mutation Res 2007;622:94-102.
17. Danesi F, Philpott M, Huebner C, Bordoni A, Ferguson LR: A Screen to test the role of IL-23 receptor in inflammatory bowel diseases. J Nutrigenet Nutrigenom 2008;6:305.
18. Roy NC, Barnett MPG, Knoch B, Dommels Y, McNabb WC: Nutrigenomics applied to an animal model of inflammatory bowel diseases transcrip-tomic analysis of the effects of eicosapentaenoic acid-and arachidonic acid-enriched diets. Mut 2007;622;103-116.
19. Knoch B, Barnett M P, Zhu S, et al: Genome-wide analysis of dietary eicosapentaenoic acid-and oleic acid-induced modulation of colon inflammation in interleukin-10 gene-deficient mice. J Nutrigenet Nutrigenomics 2009;2;1:9-28.
20. Nones K, Knoch B, Dommels YE, et al: Multidrug resistance gene deficient (mdr1a-/-) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J Appl Microbiol 2009;107: 557-566.
21. Dommels YE, Butts CA, Zhu S, et al: Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice. Genes Nutr 2007;2:209-223.
22. Nones K, Dommels YE, Martell S, et al: The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases. Br J Nutr 2009;101:169-181.
23. Lin HM, Edmunds SI, Helsby NA, Ferguson LR, Rowan DD: Nontargeted urinary metabolite profiling of a mouse model of Crohn's disease. J Proteome Res 2009;8:2045-2057.
24. Ferguson LR: Biomarkers as endpoints in intervention studies; in Vineis P, Sy Garte S, Wild C (eds): Molecular Epidemiology of Chronic Diseases: New Techniques and Approaches. Chichester, John Wiley & Sons, 2008, pp 255-266.
25. Kornman K, Rogus J, Roh-Schmidt H, et al: Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical a nutrige-netics proof of concept. Nutrition 2007;23:844-852.
26. Kaput J, Allen L, Ames BN, et al: The case for strategic international alliances to harness nutritional genomics for public and personal health. Br J Nutr 2005;94:623-632.